These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24686772)

  • 21. Optimization of training and measurement protocol for eNose analysis of urine headspace aimed at prostate cancer diagnosis.
    Capelli L; Bax C; Grizzi F; Taverna G
    Sci Rep; 2021 Oct; 11(1):20898. PubMed ID: 34686703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
    Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
    Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role of multifactorial evaluation of prostatic 3T MRI in patients with elevated prostatic-specific antigen levels: prospective comparison with ultrasound-guided transrectal biopsy.
    Ferda J; Kastner J; Hora M; Hes O; Fínek J; Topolčan O; Kreuzberg B
    Anticancer Res; 2013 Jun; 33(6):2791-5. PubMed ID: 23749943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
    Marks LS; Fradet Y; Deras IL; Blase A; Mathis J; Aubin SM; Cancio AT; Desaulniers M; Ellis WJ; Rittenhouse H; Groskopf J
    Urology; 2007 Mar; 69(3):532-5. PubMed ID: 17382159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
    Rigau M; Morote J; Mir MC; Ballesteros C; Ortega I; Sanchez A; Colás E; Garcia M; Ruiz A; Abal M; Planas J; Reventós J; Doll A
    Prostate; 2010 Dec; 70(16):1760-7. PubMed ID: 20672322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A performance analysis of the presence of malignant circulating prostate cells as a predictive factor for the detection of prostate cancer in the first, second and third prostate biopsy.
    Murray NP; Reyes E; Tapia P; Badinez L; Orellana N; Fuentealba C; Olivares R; Dueñas R
    Arch Esp Urol; 2013 May; 66(4):335-41. PubMed ID: 23676536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study.
    Trabulsi EJ; Tripathi SK; Gomella L; Solomides C; Wickstrom E; Thakur ML
    BJU Int; 2017 Jun; 119(6):885-895. PubMed ID: 28075510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis.
    Elshafei A; Kartha G; Li Y; S Moussa A; Hatem A; Gao T; Jones JS
    Prostate; 2014 Sep; 74(12):1183-8. PubMed ID: 24962004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Repeat prostate biopsies following a first negative biopsy in a context of an elevated prostate specific antigen].
    Floc'h AP; Benmeziani R; Delpech PO; Doré B; Fromont G; Irani J
    Prog Urol; 2012 Oct; 22(12):718-24. PubMed ID: 22999119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: comparison to prostatic biopsy.
    Murray NP; Reyes E; Tapia P; Orellana N; Dueñas R; Fuentealba C; Badinez L
    Arch Esp Urol; 2011 Dec; 64(10):961-71. PubMed ID: 22228894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostate cancer and dogs sense of smell: opportunities of noninvasive diagnostics].
    Protoshhak VV; Andreev EA; Karpushhenko EG; Slepcov AV; Ovchinnikov DV; Alentev SA; Lazutkin MV; Mamaenko AV; Mamaenko TV
    Urologiia; 2019 Dec; (5):22-26. PubMed ID: 31808627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocytochemical study of urine cytological preparations from secondary prostatic adenocarcinoma involving the urinary bladder.
    Mai KT; Ahmed I; Robertson SJ; Belanger EC; Veinot JP; Islam S
    Diagn Cytopathol; 2008 Oct; 36(10):715-20. PubMed ID: 18773445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer.
    Tinzl M; Marberger M; Horvath S; Chypre C
    Eur Urol; 2004 Aug; 46(2):182-6; discussion 187. PubMed ID: 15245811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
    Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
    Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [DiaPat urine test for prostate cancer. Predictive value for results of transrectal ultrasound-guided prostate biopsies].
    Oberpenning F; von Knobloch R; Sprute W; Roth S; Rathert M; Bierer S; Gerss J; Semjonow A
    Urologe A; 2008 Jun; 47(6):735-9. PubMed ID: 18496663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCA3: a molecular urine assay for predicting prostate biopsy outcome.
    Deras IL; Aubin SM; Blase A; Day JR; Koo S; Partin AW; Ellis WJ; Marks LS; Fradet Y; Rittenhouse H; Groskopf J
    J Urol; 2008 Apr; 179(4):1587-92. PubMed ID: 18295257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of prostate cancer using a voltammetric electronic tongue.
    Pascual L; Campos I; Vivancos JL; Quintás G; Loras A; Martínez-Bisbal MC; Martínez-Máñez R; Boronat F; Ruiz-Cerdà JL
    Analyst; 2016 Aug; 141(15):4562-7. PubMed ID: 27375181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting.
    Shappell SB; Fulmer J; Arguello D; Wright BS; Oppenheimer JR; Putzi MJ
    Urology; 2009 Feb; 73(2):363-8. PubMed ID: 18995890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL; Mai KT
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.